Licensing agreement gives Grünenthal GmbH exclusive rights in Europe and Latin America. Read More »

FDA approves injectable gel to plump lips and reduce lines around the lips. Read More »

The Pharmacy Podcast Show recently marked a milestone - its 300th episode. Read More »

The American Pharmacists Association's (APhA) annual awards and honors program is set for March 24-27, 2017, and award nominations are being accepted now. Read More »

The CIO interactive community recognized CVS Health for excellence and leadership in IT. Read More »

The clinical trial evaluating patritumab as a treatment in non-small cell lung cancer will not proceed to the second part. Read More »

Kalia partners with Benzer Pharmacy to establish franchise in Tampa, Florida. Read More »

Upgraded website, plain language disclosures and frequent updates will help health care providers make informed decisions when purchasing health IT. Read More »

Liver disease therapy Ocaliva granted accelerated approval by FDA. Read More »

IUDs and oral contraceptives donated to help prevent pregnancy in areas affected by the zika virus. Read More »

CVS Pharmacy becomes the exclusive drugstore for the "Partner in Healthy Living" initiative. Read More »

First branded IV antibiotic approved for use with children in more than 10 years. Read More »

Zinbryta approved to treat relapsing forms of MS; only one monthly injection required. Read More »

Initial five stops on the tour announced; second consecutive summer tour to train pharmacists in point-of-care testing. Read More »

The interactive forum brings independent pharmacists together to collaborate on ways to expand business, improve profits and help their patients. Read More »

Webinar compliments NACDS efforts in Puerto Rico to encourage women to discuss the zika virus with their health care providers and pharmacists. Read More »

Expanded exclusion lists also could impact pharmacies, patients. Read More »

Sanofi announced this week that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the Food and Drug Administration (FDA) has recommended the approval of a new drug application from the company. Read More »

The Committee for Medicinal Products for Human Use (CHMP) within the European Medicines Agency has recommended the approval of saxa/dapa for use in treating type-2 diabetes. Read More »

Incyte Corp. announced that approximately 20 abstracts associated with its clinical developments will be presented at the American Society of Clinical Oncology (ASCO) and the European Hematology Association (EHA) meetings in 2016. Read More »